Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 18, 2026.
|Videos|November 29, 2016
Alzheimer Disease: Amyloid Burden & Loneliness
Author(s)Bobby Lazzara, MD
Is loneliness predictive of preclinical Alzheimer disease? Dr. Lazzara discusses a study of cortical amyloid burden and loneliness in older adults.
Advertisement
Utilizing measurements of cortical amyloid burden and UCLA-3 loneliness scores, researchers asked if loneliness could be a neuropsychiatric preclinical symptom of Alzheimer disease. In this Medical News Minute, developed exclusively for Neurology Times, Dr. Bobby Lazzara reports on
Advertisement
Related to this article
Microstructure Imaging has announced that the FDA cleared its MICSI-PET, an MR-guided PET enhancement platform with automated amyloid Centiloid and tau quantification.
Subgroup analyses from the phase 2 ADDRESS-LC trial showed bezisterim significantly improved fatigue, malaise, and cognition in long COVID patients with more severe baseline symptoms.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 11, 2026.
The clinical neuropsychologist and assistant professor of medicine at the Icahn School of Medicine at Mount Sinai discussed the mechanisms behind brain fog from Long COVID and its potential links to Alzheimer risk.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves UX111, First Gene Therapy for Pediatric Sanfilippo Syndrome Type A
2
FDA Clears Phase 1b/2 Trial of CAR T-Cell Therapy C-CAR168 for Refractory Progressive Multiple Sclerosis
3
Episode 175: Advancing the Ways of Treating Cluster Headache
4
FDA Approves Levacetylleucine for Ataxia-Telangiectasia
5